Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory study.
Papo M, Friedrich C, Delaval L, Boysson H, Viallard JF, Bachmeyer C, Sené T, Humbert S, Duffau P, Contis A, Agard C, Gombert B, Puyade M, Foucher A, Alary AS, Danlos FX, Régent A, Mouthon L, Guillevin L, Samson M, Kosmider O, Terrier B; French Vasculitis Study Group. Papo M, et al. Among authors: friedrich c. Rheumatology (Oxford). 2022 Feb 2;61(2):775-780. doi: 10.1093/rheumatology/keab337. Rheumatology (Oxford). 2022. PMID: 33836046
Atypical splice-site mutations causing VEXAS syndrome.
Templé M, Duroyon E, Croizier C, Rossignol J, Huet T, Friedrich C, Zalmai L, Priollet P, Hayem G, Tournillhac O, Le Guenno G, Hermine O, Terrier B, Kosmider O. Templé M, et al. Among authors: friedrich c. Rheumatology (Oxford). 2021 Dec 1;60(12):e435-e437. doi: 10.1093/rheumatology/keab524. Rheumatology (Oxford). 2021. PMID: 34213531 No abstract available.
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia.
Decroocq J, Birsen R, Montersino C, Chaskar P, Mano J, Poulain L, Friedrich C, Alary AS, Guermouche H, Sahal A, Fouquet G, Gotanègre M, Simonetta F, Mouche S, Gestraud P, Lescure A, Del Nery E, Bosc C, Grenier A, Mazed F, Mondesir J, Chapuis N, Ho L, Boughalem A, Lelorc'h M, Gobeaux C, Fontenay M, Recher C, Vey N, Guillé A, Birnbaum D, Hermine O, Radford-Weiss I, Tsantoulis P, Collette Y, Castellano R, Sarry JE, Pasmant E, Bouscary D, Kosmider O, Tamburini J. Decroocq J, et al. Among authors: friedrich c. Leukemia. 2022 May;36(5):1237-1252. doi: 10.1038/s41375-022-01541-0. Epub 2022 Mar 30. Leukemia. 2022. PMID: 35354920 Free PMC article.
Acquired spherocytosis due to somatic ANK1 mutations as a manifestation of clonal hematopoiesis in elderly patients.
Mansour-Hendili L, Flamarion E, Michel M, Morbieu C, Gameiro C, Sloma I, Badaoui B, Darnige L, Camard M, Lunati-Rozie A, Aissat A, Tarfi S, Friedrich C, Picard V, Garçon L, Abermil N, Kaltenbach S, Radford-Weiss I, Kosmider O, Fanen P, Bartolucci P, Godeau B, Galactéros F, Funalot B. Mansour-Hendili L, et al. Among authors: friedrich c. Am J Hematol. 2022 Aug;97(8):E285-E288. doi: 10.1002/ajh.26593. Epub 2022 May 20. Am J Hematol. 2022. PMID: 35560067 Free article. No abstract available.
The Mesenchymal Niche in Myelodysplastic Syndromes.
Friedrich C, Kosmider O. Friedrich C, et al. Diagnostics (Basel). 2022 Jul 5;12(7):1639. doi: 10.3390/diagnostics12071639. Diagnostics (Basel). 2022. PMID: 35885544 Free PMC article. Review.
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.
Kosmider O, Possémé C, Templé M, Corneau A, Carbone F, Duroyon E, Breillat P, Chirayath TW, Oules B, Sohier P, Luka M, Gobeaux C, Lazaro E, Outh R, Le Guenno G, Lifermann F, Berleur M, Le Mene M, Friedrich C, Lenormand C, Weitten T, Guillotin V, Burroni B, Boussier J, Willems L, Aractingi S, Dionet L, Tharaux PL, Vergier B, Raynaud P, Ea HK, Ménager M, Duffy D, Terrier B. Kosmider O, et al. Among authors: friedrich c. Nat Commun. 2024 Jan 30;15(1):910. doi: 10.1038/s41467-024-44811-4. Nat Commun. 2024. PMID: 38291039 Free PMC article.
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
Silvin A, Chapuis N, Dunsmore G, Goubet AG, Dubuisson A, Derosa L, Almire C, Hénon C, Kosmider O, Droin N, Rameau P, Catelain C, Alfaro A, Dussiau C, Friedrich C, Sourdeau E, Marin N, Szwebel TA, Cantin D, Mouthon L, Borderie D, Deloger M, Bredel D, Mouraud S, Drubay D, Andrieu M, Lhonneur AS, Saada V, Stoclin A, Willekens C, Pommeret F, Griscelli F, Ng LG, Zhang Z, Bost P, Amit I, Barlesi F, Marabelle A, Pène F, Gachot B, André F, Zitvogel L, Ginhoux F, Fontenay M, Solary E. Silvin A, et al. Among authors: friedrich c. Cell. 2020 Sep 17;182(6):1401-1418.e18. doi: 10.1016/j.cell.2020.08.002. Epub 2020 Aug 5. Cell. 2020. PMID: 32810439 Free PMC article.
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis.
Vazquez R, Breal C, Zalmai L, Friedrich C, Almire C, Contejean A, Barreau S, Grignano E, Willems L, Deau-Fischer B, Franchi P, Vignon M, Decroocq J, Birsen R, Goldwirt L, Kaltenbach S, Couronne L, Fontenay M, Kosmider O, Bouscary D, Chapuis N. Vazquez R, et al. Among authors: friedrich c. Blood Cancer J. 2021 Mar 19;11(3):62. doi: 10.1038/s41408-021-00448-w. Blood Cancer J. 2021. PMID: 33741892 Free PMC article. No abstract available.
716 results